10. Dr. Bares Award
CZ, SK, PL, RU, LT, LV, EE
19 000 EUR
Doc. Dr. Jan Kotrlik, CSc. (CZE), Prof. Dr. Petr Dite, DrSc. (CZE), Prof. Dr. Vladimir T. Ivashkin (RUS), Prof. Dr. Limas Kupchinskas, PhD. (Lithuania), Prof. Dr. Andrzej Nowak (POL), Prof. Dr. Anton Vavrecka, CSc. (SVK).
Brzozowski, T. et al. 2008. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation, focus on nitric oxide and lipoxins. Journal of Physiology and Pharmacology 59, Suppl 2, 89–102.
Hucl, T. et al. 2007. High Cancer-Specific Expression of Mesothelin (MSLN) Is Attributable to an Upstream Enhancer Containing a Transcription Enhancer Factor–Dependent MCAT Motif. Cancer Res 67: 5, 9055–9065.
Hlavaty, T. et al. 2007. Predictive Model for the Outcome of Infliximab Therapy in Crohn’s Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors. Inflamm Bowel Dis. 13: 4, 372–379.
Kondrackiene, J. et al. 2007. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol. 13: 46, 6226–6230.
Vítek, L. and Schwertner, H. A. 2007. The heme catabolic pathway and its protective effects on oxidative stress–mediated diseases. Advances in Clinical Chemistry, vol. 43., 57 pp.